Our brain tumour initiative – vital new funding for brain tumour research
To address this, in 2014 we launched our new paediatric brain tumour initiative.
We wanted to increase the pace of research into these devastating tumours. The aim is to speed up the development of new treatments. The treatments need to be more effective, helping more young patients to survive, but also less harmful, enabling these patients to not only survive but thrive.
Under this new initiative, we committed £3 million over three years for new research into paediatric brain tumours.
In spring 2015 we awarded the first four grants, at a total cost of £1.8m. Dr Steve Pollard was the recipient of one of these grants.
Shining the light on incurable brain tumours
In a project that brings together research teams from the UK, Canada and Sweden, Steve is studying an incurable brain tumour called paediatric glioblastoma (pGBM).
The teams are working together, pooling expertise and resources, in an ambitious project that promises to take forward our understanding of the function and behaviour of certain cancer genes in pGBM.
Steve gave us an intriguing insight into their work to unravel the intricate genetic mechanisms underlying these devastating tumours.
We were able to see for ourselves the amazing state-of-the-art facilities available to them at the Centre for Regenerative Medicine; we had the opportunity to study brain tumour cells under high-powered microscopes and view fascinating time-lapse footage of cancer cells multiplying.
The ultimate aim of this work is the development or discovery of drugs that can combat these deadly tumours.